
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Kazia Therapeutics is a biotechnology business based in Australia. Kazia Therapeutics shares (KZA) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian dollars. Kazia Therapeutics has a trailing 12-month revenue of around $15.2 million. If you're looking to buy shares, check out the steps below.
How to buy shares in Kazia Therapeutics
- Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the ASX. Our table can help you choose.
- Open and fund your brokerage account. Complete an application with your personal and financial details, such as your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
- Search for Kazia Therapeutics . Find the share by name or ticker symbol: KZA. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Kazia Therapeutics reaches your desired price. Look into dollar-cost averaging to spread out your risk, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At today's price, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
- Check on your investment. Congratulations, you own a part of Kazia Therapeutics . Optimise your portfolio by tracking how your stock and the business performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that affect your stock.
Our top pick for
US stocks

Our top pick for
Overall broker

Our top pick for
Low-cost broker

What's in this guide?
- Kazia Therapeutics key stats
- Compare share trading platforms
- Is Kazia Therapeutics stock a buy or sell?
- Kazia Therapeutics performance over time
- Kazia Therapeutics 's financials
- How volatile are Kazia Therapeutics shares?
- Does Kazia Therapeutics pay a dividend?
- Have Kazia Therapeutics shares ever split?
- Other common questions
Kazia Therapeutics stock price (ASX:KZA)
Use our graph to track the performance of KZA stocks over time.Kazia Therapeutics shares at a glance
52-week range | $0.585 - $1.65 |
---|---|
50-day moving average | $0.8179 |
200-day moving average | $1.116 |
Target price | $1.9 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-0.116 |
Compare share trading platforms
Is it a good time to buy Kazia Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Kazia Therapeutics price performance over time
Historical closes compared with the last close of A$0.625
1 week (2022-06-28) | 1.63% |
---|---|
1 month (2022-06-03) | -22.84% |
3 months (2022-04-05) | -42.92% |
6 months (2022-01-05) | -48.77% |
1 year (2021-07-05) | -54.55% |
---|---|
2 years (2020-07-03) | 22.55% |
3 years (2019-07-05) | 56.25% |
5 years (2017-07-05) | -86.98% |
Kazia Therapeutics financials
Revenue TTM | $15.2 million |
---|---|
Gross profit TTM | $15.2 million |
Return on assets TTM | -19.59% |
Return on equity TTM | -52.76% |
Profit margin | -99.27% |
Book value | 0.193 |
Market capitalisation | $82.8 million |
TTM: trailing 12 months
Kazia Therapeutics share dividends
We're not expecting Kazia Therapeutics to pay a dividend over the next 12 months.
Have Kazia Therapeutics 's shares ever split?
Kazia Therapeutics 's shares were split on a 1:10 basis on 17 November 2017. So if you had owned 10 shares the day before the split, the next day you would own 1 share. This wouldn't directly have changed the overall worth of your Kazia Therapeutics shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Kazia Therapeutics shares which in turn could have impacted Kazia Therapeutics 's share price.
Kazia Therapeutics share price volatility
Over the last 12 months, Kazia Therapeutics 's shares have ranged in value from as little as $0.585 up to $1.65. A popular way to gauge a stock's volatility is its "beta".
Beta measures a share's volatility in relation to the market. The market (AU average) beta is 1, while Kazia Therapeutics 's is 2.767. This would suggest that Kazia Therapeutics 's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Kazia Therapeutics overview
Kazia Therapeutics Limited, an oncology-focused biotechnology company, develops anti-cancer drugs. Its lead development candidate is Paxalisib, a small molecule, brain-penetrant inhibitor of the PI3K/Akt/mTor pathway, which is developed as a potential therapy for glioblastoma. It is also developing EVT801, an investigational new drug for various forms of cancer. The company was formerly known as Novogen Limited and changed its name to Kazia Therapeutics Limited in November 2017. Kazia Therapeutics Limited was incorporated in 1994 and is based in Sydney, Australia.
Stocks similar to Kazia Therapeutics
Kazia Therapeutics in the news
US FDA AWARDS ORPHAN DRUG DESIGNATION (ODD) TO PAXALISIB FOR AT/RT, A RARE FORM OF CHILDHOOD BRAIN CANCER
POSITIVE DATA FOR PAXALISIB IN TWO CHILDHOOD BRAIN CANCERS PRESENTED AT 20TH ISPNO ANNUAL MEETING
Quite a few insiders invested in Kazia Therapeutics Limited (ASX:KZA) last year which is positive news for shareholders
Frequently asked questions
More guides on Finder
-
How to invest in the Australia Sunny Glass Group IPO
Everything we know about the Australia Sunny Glass Group IPO, plus information on how to buy in.
-
How to buy Kincora Copper (KCC) shares
Steps to owning and managing Kincora Copper shares.
-
How to invest in the Dragon Mountain Gold IPO
Everything we know about the Dragon Mountain Gold IPO, plus information on how to buy in.
-
How to buy Arcadia Minerals (AM7) shares
Steps to owning and managing Arcadia Minerals shares.
-
How to buy Nexgen Energy (NXG) shares
Steps to owning and managing Nexgen Energy shares.
-
How to buy Keypath Education (KED) shares
Steps to owning and managing Keypath Education shares.
-
What are green bonds and how do they impact the world?
If you want to directly fund climate solutions a green bond is a great place to start. Here is how they work.
-
5 best ways to invest money in Australia in 2022
What's the best way to invest money in Australia? Find out about robo advisors, index funds, cryptocurrency and more in this guide.
-
How to buy EBR Systems (EBR) shares
Steps to owning and managing EBR Systems shares.
-
How to buy 5E Advanced Materials (5EA) shares
Steps to owning and managing 5E Advanced Materials shares.
Ask an Expert